Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Viatris Inc. (VTRS) News - StockMarketCap

Stocks›Viatris Inc.☆

● At closeAs of Jul 2, 2026

Viatris Inc.

VTRS✓

HealthcareDrug Manufacturers - Specialty & GenericNASDAQ

$16.70+3.21%

$19.45BMarket cap

-61.18xP/E ratio

8.61MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$16.70

$0.52 (+3.21%) · 24h

Key metrics

Market cap$19.45B+0.44%

Enterprise value$31.34B

Volume (24h)8.61M

P/E ratio (TTM)-61.18x

P/S ratio (TTM)1.29x

Dividend yield2.97%

Shares outstanding1.16B

Trading range

Previous close$16.18

Day range$16.28 - $16.74

52-week range$8.63 - $17.53

Viatris Inc. (VTRS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news